Bayesian Capital Management, LP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 198 filers reported holding CONMED CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$607,218
+28.1%
6,021
+12.6%
0.07%0.0%
Q4 2022$474,135
-23.6%
5,349
-31.0%
0.07%
-45.2%
Q3 2022$621,000
+46.5%
7,749
+43.9%
0.13%
+21.2%
Q3 2020$424,000
-33.6%
5,386
-39.4%
0.10%
-26.2%
Q2 2020$639,000
+28.3%
8,882
+2.1%
0.14%
+30.6%
Q1 2020$498,000
+27.0%
8,702
+148.5%
0.11%
+61.2%
Q4 2019$392,000
+33.8%
3,502
-5.3%
0.07%
+39.6%
Q3 2018$293,000
-4.6%
3,699
-11.9%
0.05%
-30.4%
Q2 2018$307,000
+12.0%
4,199
-32.3%
0.07%
+1.5%
Q4 2016$274,000
+8.7%
6,200
+3.3%
0.07%
-71.3%
Q1 2016$252,0006,0000.24%
Other shareholders
CONMED CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders